Liu Z, Alexander JL, Lin KW, Ahmad T, et al. Infliximab and Tofacitinib Attenuate Neutralizing Antibody Responses Against SARS-CoV-2 Ancestral and Omicron Variants in Inflammatory Bowel Disease Patients After 3 Doses of COVID-19 Vaccine. Gastroenterology 2023;164:300-303.
PMID: 36270334